Epigenetics in autism and other neurodevelopmental diseases

Advances in Experimental Medicine and Biology

Volumn 724, Issue , 2012, Pages 91-98

  Miyake, Kunio ^a   Hirasawa, Takae ^a   Koide, Tsuyoshi ^b   Kubota, Takeo ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b NATIONAL INSTITUTE OF GENETICS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; METHYL CPG BINDING PROTEIN; ROYAL JELLY; VALPROIC ACID;

ARTICLE; AUTISM; BRAIN FUNCTION; DEVELOPMENTAL DISORDER; DNA METHYLATION; DNA SEQUENCE; DRUG EFFECT; DRUG SAFETY; DRUG USE; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE CONTROL; GENETIC ASSOCIATION; GENETIC DISORDER; GENOME ANALYSIS; HUMAN; MALNUTRITION; MATERNAL CARE; MENTAL HEALTH; NERVE STIMULATION; NONHUMAN; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; PROTEIN FUNCTION; X CHROMOSOME; Y CHROMOSOME; BRAIN; ENVIRONMENT; GENETIC EPIGENESIS; GENETICS; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW;

AUTISTIC DISORDER; BRAIN; DEVELOPMENTAL DISABILITIES; ENVIRONMENT; EPIGENESIS, GENETIC; EPIGENOMICS; HUMANS;

EID: 84859508516     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-0653-2_7     Document Type: Article

References (55)

1. Honda H, Shimizu Y, Imai MM. Cumulative incidence of childhood autism: a total population study of better accuracy and precision. Dev Med Child Neurol 2005; 47:10-18.
2. Silverman JL, Yang M, Lord C. Behavioural phenotyping assays for mouse models of autism. Nature Review Neuroscience 2010; 490:490-502.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Diseases. 4th ed, APA, Washington DC, 1994.
4. World Health Organization. The ICD-10 Classification of Mental and Behavioural Diseases. Geneva, Switzerland, 1992.
5. Herbert MR. Contributions of the environment and environmentally vulnerable physiology to autism spectrum diseases. Curr Opin Neurol 2010; 23:103-110.
6. Persico AM, Bourgeron T, Persico AM. Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci 2006; 29:349-358.
7. Zoghbi HY. Postnatal neurodevelopmental diseases: meeting at the synapse?. Science 2003; 302:826-830.
8. Basic investigation report for handicapped children. report by Ministry of Health, Welfare and Labor, Japan. 2005 (in Japanese).
9. Yeargin-Allsopp M, Rice C, Karapurkar T. Prevalence of Autism in a US Metropolitan Area. JAMA 2003; 289:49-55.
10. Holden C. Autism Now. Science 2009; 323:565.
11. Fombonne E. Epidemiology of pervasive developmental diseases. Pediatric Research 2009; 65:591-598.
12. Hoekstra RA, Bartels M, Hudziak JJ. Genetics and environmental covariation between autistic traits and behavioral problems. Twin Res Hum Genet 2007; 10:853-860.
13. Qiu J. Epigenetics: unfinished symphony. Nature 2006; 441:143-145.
14. Guy J, Herndrich B, Hormes M. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 2001; 27:322-326.
15. KubotaT, Das S, Christian SL. Methylation-specific PCR symplifies imprinting analysis. Nat Genet 1997; 16:16-17.
16. Kubota T, Nonoyama S, Tonoki H. A new assay for the analysis ofX-chromosome inactivation based on methylation-specific PCR. Hum Genet 1999; 104:49-55.
17. Xue F, Tian XC, Du F. Aberrant patterns of X chromosome inactivation in bovine clones. Nat Genet 2002; 31:216-220.
18. Nolen LD, Gao S, Han Z. X chromosome reactivation and regulation in cloned embryos. Developmental Biology 2005; 279:525-540.
19. Kubota T, Wakui K, Nakamura T. Proportion of the cells with functional X disomy is associated with the severity of mental retardation in mosaic ring X Turner syndrome females. Cytogenet Genome Res 2002; 99:276-284.
20. Okano M, Bell DW, Habe DA. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999; 99:247-257.
21. Shirohzu H, Kubota T, Kumazawa A. Three novel DNMT3B mutations in Japanese patients with ICF syndrome. Am J Med Genet 2002; 112:31-37.
22. Kubota T, Furuumi H, Kamoda T. ICF syndrome in a girl with DNA hypomethylation but without detectable DNMT3B mutation. Am J Med Genet A 2004; 129:290-293.
23. Amir RE, Van den Veyver IB, Wan M. Rett syndrome is caused by mutations inX-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999; 23:185-188.
24. Chunshu Y, Endoh K, Soutome M. A patient with classic Rett syndrome with a novel mutation in MECP2 exon 1. Clin Genet 2006; 70:530-531.
25. Chen WG, Chang Q, Lin Y. Derepression of BDNF Transcription Involves Calcium-Dependent PhosphorylationofMeCP2. Science; 2003; 302:885-889.
26. Martinowich K, Hattori D, Wu H. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 2003; 302:890-893.
27. Horike S, Cai S, Miyano M. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat Genet 2005; 37:31-40.
28. Itoh M, Ide S, Takashima S. Methyl CpG-binding protein 2, whose mutation causes Rett syndrome, directly regulates Insulin-like Growth Factor Binding Protein 3 in mouse and human Brains. J Neuropathol Exp Neurol 2007; 66:117-123.
29. Jiang YH, Sahoo T, Michaelis RC. A mixed epigenetic/genetic model for oligogenic inheritance of autism with a limited role for UBE3A. Am J Med Genet A 2004; 131:1-10.
30. Beaudet AL. Autism: highly heritable but not inherited. Nat Med 2007; 13:534-536.
31. Beaudet AL. Allan Award lecture: Rare patients leading to epigenetics and back to genetics. Am J Hum Genet 2008; 82:1034-1038.
32. Fombonne E. Epidemiology of pervasive developmental diseases. Pediatr Res 2009; 65:591-598.
33. Bailey A, Le Couteur A, Gottesman I. Autism as a strongly genetic disease: evidence from a British twin study. Psychol Med 1995; 25:63-77.
34. Zafeiriou DI, Ververi A, Vargiami E. Childhood autism and associated comorbidities. Brain Dev 2007; 29:257-272.
35. Burdge GC, Lillycrop KA, Phillips ES. Folic acid supplementation during thejuvenile-pubertal period in rats modifies the phenotype and epigenotype induced by prenatal nutrition. JNutr 2009; 139:1054-1060.
36. Jessberger S, Nakashima K, Clemenson GD. Epigenetic modulation of seizure-induced neurogenesis and cognitive decline. J Neurosci 2007; 27:5967-5975.
37. Weaver IC, Cervoni N, Champagne FA. Epigentic programming by maternal behavior. Nat Neurosci 2004; 9:847-554.
38. Tsankova NM, Berton O, Renthal W. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 2006; 9:519-525.
39. Ma DK, Jang MH, Guo JU. Neuronal activity-induced Gadd45b promotes epigenetic DNA demethylation and adult neurogenesis. Science 2009; 323:1074-1077.
40. Kumar A, Choi KH, Renthal W. Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum. Neuron 2005; 48:303-314.
41. Pascual M, Boix J, Felipo V. Repeated alcohol administration during adolescence causes changes in the mesolimbic dopaminergic and glutamatergic systems and promotes alcohol intake in the adult rat. J Neurochem 2009; 108:920-931.
42. Renthal W, Nestler EJ. Epigenetic mechanisms in drug addiction. Trends Mol Med 2008; 14:341-350.
43. Fraga MF, Ballestar E, Paz MF. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA 2005; 102:10604-10609.
44. Watanabe H, Fukuoka H, Sugiyama T. Dietary folate intake during pregnancy and birth weight in Japan. European J Nutr 2008; 47:341-347.
45. Park JH, Stroffers DA, Nicholles RD. Development oftype 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pcbd. J Clin Invest 2008; 118:2316-2324.
46. Kucharski R, Maleszka J, Foret S. Nutritional control of reproductive status in haneybees via DNA methylation. Science 2008; 319:1827-1830.
47. Rimland B. Controversies in the treatment of autistic children: vitamin and drug therapy. J Child Neurol 1998; 3:68-72.
48. James SJ, Cutler P, MelnykS. Metabolic biomarkersofincreased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 2004; 20:1611-1617.
49. Moretti P, Sahoo T, Hyland K. Cerebral folate deficiency with developmental delay, autism and response to folinic acid. Neurology 2005; 64:1088-1090.
50. Laird PW. Principles and challenges of genome-wide DNA methylation analysis. Nat Rev Genet 2005; 11:191-203.
51. Varley KE, Mitra RD. Bisulfite Patch PCR enables multiplexed sequencing of promoter methylation across cancer samples. Genome Res 2010. [Epub ahead of print].
52. Ohtsuki A, Kimura MT, Minoshima M. Synthesis and properties of PI polyamide-SAHA conjugate. Tetrahedron Lett 2009; 50:7288-7292.
53. Coufal NG, Garcia-Perez JL, Peng GE. L1 retrotransposition in human neural progenitor cells. Nature 2009; 460:1127-1131.
54. Muotri AR, Chu VT, Marchetto MCN. Somatic mosaicism in neuronal precursor cells mediated by L1 retrotransposition. Nature 2005; 435:903-910.
55. Muotri AR, Zhao C, Marchetto MCN. Environmental Influence on L1 Retrotransposons in the Adult Hippocampus. Hypoocumpus 2009; 19:1002-1007.